
Before you publish a claim about PRP treatments, sort it into one of three bins. You can say what PRP is and how your practice prepares it, and you can talk about what research is looking at if you add controls. You can’t promise an outcome, name a condition as treated, or call it approved. Here’s how I sort each one.
TLDR: Every claim about PRP treatments lands in one of three bins: say it, say it with controls, or don’t say it. The test behind the bins is evidence, and softer words like may and helps don’t lower the bar. The device that prepares PRP is cleared for a stated use, and that doesn’t make PRP approved. Keep reading for the table, and for the four places claims hide on a site.
Important Note
This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing and consulting company, not a law firm. Nothing here implies FDA approval of any product or any use. Most cell, tissue and exosome products marketed to patients are not FDA approved, and the few cell-based products the FDA has approved are approved only for specific labeled indications. Nothing here promises a marketing or business outcome. Regulations change and enforcement varies by state. Confirm current requirements with qualified legal and compliance counsel before you act on anything you read here.
What can I legally claim about PRP treatments? I’ve worked with PRP since 2016, and I still don’t answer that with a yes or a no. I answer it with a question.
What’s the evidence for that sentence? We put that to practices and to vendors, and what we usually get back is vendor materials. Sometimes it’s a public clinical trial. And often it’s not much at all.
So I’m going to go claim by claim. Then I’ll show you where the bad ones hide, because it’s usually a spot nobody thinks of as copy.
The Short Answer: Three Bins for Every Claim About PRP Treatments
You can say what PRP is and how your practice prepares it. You can say what research is looking at, if you add controls. You can’t promise an outcome, name a condition as treated, or call PRP approved.
That’s it. Three bins.
Let’s define the term first. PRP is platelet-rich plasma. It’s platelets and plasma concentrated from the patient’s own blood. It contains no stem cells.
That definition describes what’s in the tube. Add what PRP does for a condition, and now you’re in a different bin.
Here’s how the common ones sort.
| Kind of Claim | Where It Lands | What It Needs |
|---|---|---|
| What PRP is | Say it | Accurate wording and your clinician’s sign-off |
| How your practice prepares it | Say it | To match what happens in the room |
| What research is looking at | Say it with controls | Evidence behind the takeaway, the study linked, the limits, no promise |
| What the device is cleared for | Say it with controls | The cleared use in the FDA’s words, the off-label status, and counsel’s review |
| Do Not Use: “PRP treats [a condition]” | Don’t say it | A rewrite, and “may” or “helps” won’t fix it |
| Do Not Use: “You’ll see [a result] in [a time]” | Don’t say it | Removal |
| Do Not Use: “Our PRP therapy is FDA approved” | Don’t say it | Removal |
What this means for your practice: Before you ask if a sentence sounds good, ask which bin it’s in. The bins come from the federal rules. Your state medical board has its own advertising rules, and counsel checks those too.
Ad platforms add their own layer, and what Facebook allows for PRP ads is a separate read.
What Evidence Does a Claim About PRP Treatments Need?
A health claim needs what the FTC calls “competent and reliable scientific evidence.” For a health benefit, the FTC says that generally means “randomized, controlled human clinical testing.” A softer word doesn’t lower that bar.
So what does the rule actually say? It’s in the FTC’s Health Products Compliance Guidance, published in December 2022. That page says “FTC advertising law applies to all products and claims.”
All products. A PRP page doesn’t get a pass.
Most people think a softer word makes the claim safe. The guidance says “Vague qualifying terms are inadequate,” and the two examples it gives are the words may and helps.
Then there’s the brochure. A rep’s pitch to a clinic owner routinely includes statements that aren’t FDA compliant, and in this industry that’s normal. What I’ve watched is where the pitch goes next: into the clinic’s ads and its own marketing materials. Even a “best thing since sliced bread” kind of line gets repeated to the clinic’s patients and its network.
So let’s say the kit maker’s brochure makes the claim for you. According to who? Once that line is on your site, it’s your line.
That same guidance says “All parties who participate directly in marketing and promotion” have “an obligation to make sure that claims are presented truthfully” and to check their support. It’s the same reason rules for biologics reps cover superlatives and research framing.
Can You Talk About PRP Research?
Sometimes, and it’s harder than it looks. A line about a study is still a claim, so the evidence has to back what a reader takes from it. If it does, link the study, say what the authors measured and what the limits were, and have a clinician sign off.
I believe in this field, and so I’m not going to tell you to stay quiet about the research. Just stop before the line that tells the reader what it means for them. That line is the promise.
And stating the limits doesn’t lower the bar. The FTC’s guidance says a marketer is “equally responsible” for claims “suggested or reasonably implied in advertising.” So ask what a reader walks away thinking. If the study can’t back that up, the line goes in the third bin.
Two more controls. Say what kind of study it was. And put the status next to it: this use of PRP is off-label, and the FDA has not evaluated PRP for this use. Say the study type and the level of evidence beside the line, so a small early study does not read like proof.
The next control is a person. Our content process has two review passes. My compliance team checks the claim language, the disclosures, the accuracy and the structure. And the practice’s own clinician signs off on anything clinical.
The FTC’s guidance also says an ad is judged by its “net impression,” all the elements together: the text, the product name, the images. So the headline over a research line counts too. The same test applies to what stem cell ads can claim.
Is PRP FDA Approved, FDA Cleared, or a 361 Product?
None of the three. The systems that prepare PRP are medical devices, cleared through the 510(k) process for a stated use. And blood components are on the list of things the federal tissue rules don’t treat as cell and tissue products.
The FDA’s 510(k) page says a device maker has to notify the FDA before it markets a device. And the FDA’s platelet and plasma separator classification lists a Class 2 device with a 510(k) submission.
The definition starts with “Preparation of autologous platelet rich plasma from a small sample of peripheral blood”. Autologous means the patient’s own. And it ends with “for mixing with bone graft to improve handling characteristics.”
Read that again. Bone graft handling. That’s the cleared use for that class of PRP systems, and it doesn’t make PRP approved or cleared for joints, hair, skin or anything else.
Those uses are off-label practice of medicine, which means outside the cleared use. Marketing doesn’t get to borrow the word cleared for them. And I’d say that on the page in plain words, right next to the description of what PRP is.
Can you mention the device at all? I’d put it in the middle bin.
If you say cleared, say cleared for what, in the FDA’s words. Say that your use is off-label. Then run the line past counsel.
And look up your own system first. That same 510(k) page links to a database where anyone can read what a device was cleared for. If you can’t find yours, ask the supplier for the clearance number and take the answer to counsel.
Now 361 and 351. Those are labels for human cell and tissue products, called HCT/Ps. So which one is PRP? Neither.
The definitions section, 21 CFR 1271.3, lists the articles that are not HCT/Ps. That list includes whole blood, blood components and blood derivative products. And PRP starts as a blood draw. So 361 and 351 are the wrong labels for it, and counsel confirms how that applies to a specific preparation. Those labels belong to a different conversation, where minimally manipulated is a classification term.
Can You Post Reviews and Patient Stories That Mention Results?
Not without evidence for the result. When a review goes on your site, in a post or in an ad, the FTC’s guidance says you “must have appropriate scientific evidence” for the claim it implies. And a “Results not typical” line doesn’t fix that.
I get why clinics want these. Reviews matter more when the patient is making a bigger financial decision.
Then there’s the FTC’s questions and answers on endorsements, modified July 15, 2025. Take an endorser whose result isn’t what people generally get. Then the ad “must make clear to the audience what the generally expected results” are.
And how do you state the generally expected results? With evidence. So it all goes back to the same question.
That page also says a connection people wouldn’t expect between the endorser and the marketer “should be disclosed clearly and conspicuously.” So I’d check every testimonial on the site for that disclosure.
If the practice is a HIPAA covered entity, HHS says it needs the patient’s written authorization, with limited exceptions, before it uses their health information for marketing. Counsel decides how that applies. The federal review rules in plain terms are worth a read before your team asks for a review.
Where Does a Claim Hide on a Clinic Website?
In the places nobody thinks of as copy: headings, image alt text, meta descriptions and reviews. The FTC’s list of what counts as advertising includes statements “on the internet and in other digital content.” I read that to cover all four, and counsel decides the edge cases.
Here’s where I’d look first:
- The headings and subheadings on every service page.
- The image alt text, the short description attached to a picture.
- The page title and meta description that show up in a search result.
- The reviews and patient stories pulled onto the page.
In each spot I’d ask one thing. Does it say more than the page around it? If it does, that’s the claim a reader walks away with.
The keyword you build the page around is a compliance decision too, because it ends up in the title and the heading. And check the old landing pages that are still indexed. If a search can still find a page, I’d read it like it went live today.
Take a Practice That Wrote Its PRP Page From a Brochure
Take a practice with two physicians and a physician assistant that added PRP about a year ago. A part-time marketing coordinator keeps the website. This scenario is illustrative and does not describe any Regen Portal client.
The Challenge: The PRP page was written from the kit maker’s brochure. The headline names a condition, a subheading says the system is FDA cleared, and reviews that mention results sit under it.
The Approach: The coordinator sorts every claim about PRP treatments on the page into the three bins. The headline and the cleared line get flagged, and so do the reviews.
The Compliance Check: One of the physicians signs off on the clinical wording, and the cleared line goes to counsel with the FDA’s classification page attached. The alt text and the meta description get read too. One names the same condition, and so it comes out. The reviews that mention results come off the page too.
What Changed: The page got shorter. And the team had a written list of what they can say and why.
Frequently Asked Questions
Can I Say PRP Is FDA Approved?
No. The systems that prepare PRP are devices cleared for a stated use, and that doesn’t make PRP approved or cleared for any other use. Cleared is not approved, and the words FDA approved don’t belong on a PRP page.
Can I Say PRP Uses the Patient’s Own Blood?
Yes. That’s what PRP is: platelets and plasma concentrated from the patient’s own blood. It’s a description, and it sits in the first bin. Just watch where the sentence goes next, because once it says what that does for a condition, it needs evidence.
Can I Cite Studies About PRP?
Sometimes, with controls. A line about a study is still a claim, so the evidence has to back what a reader takes from it. Link the study, say what the authors measured and what the limits were, and have your clinician sign off.
Can I Say PRP ‘May Help’?
No, not on the strength of the word may. The FTC’s guidance says “Vague qualifying terms are inadequate,” and its examples are the words may and helps. A softer verb is still a claim, and it needs the same evidence.
Does a Claim About PRP Treatments Count in a Meta Description?
I treat it as one. The FTC’s list of advertising includes statements “on the internet and in other digital content,” and a meta description is text you wrote to get the click. Counsel decides the edge cases.
Key Takeaways
- Every claim about PRP treatments lands in one of three bins.
- You can say what PRP is and how your practice prepares it.
- A research line is still a claim, and it needs evidence behind it, the limits stated and a clinician’s sign-off.
- The device is cleared for a stated use, and that doesn’t make PRP approved.
- A review that mentions a result needs evidence once you publish it.
- Claims hide in headings, alt text, meta descriptions and reviews.
Let’s Talk Strategy
Before you publish the next claim about PRP treatments, ask which bin it’s in.
Going through a whole site and flagging each phrase with the reason is what we do when we review a practice’s marketing. The legal call stays with your counsel.
PS: Is there one sentence on your PRP page that you keep going back and forth on? I can tell you which bin I’d put it in. Send it to me and I’ll take a look.
Email: hello@regenportal.com
YouTube: Subscribe to the channel
About Regen Portal
Regen Portal is a marketing and consulting company built for the regenerative medicine industry. We handle practice consulting, marketing compliance, search engine optimization, content creation, social media management, paid advertising, website development, branding, and AI and ops consulting for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.
About the Author
Oscar Tellez is the founder of Regen Portal, a marketing and consulting company built for the regenerative medicine industry. He has been in this industry since 2015. He started in medical sales and has worked with PRP since 2016. He has reached hundreds of practices and over 200 doctors through sales, teaching and marketing. He holds a B.S. in Exercise Science and Health Promotion from Florida Atlantic University.


